Market Overview:
The global high-throughput sequencing (HTS) market is expected to grow at a CAGR of 16.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for HTS services for life science research and drug discovery, and the growing application of HTS in oncology and hereditary disease detection. North America is expected to dominate the global high-throughput sequencing (HTS) market during the forecast period, followed by Europe and Asia Pacific.
 Industry Outlook.svg)
Product Definition:
High-throughput sequencing (HTS) is a technology that allows researchers to sequence many DNA or RNA fragments at once. This technology is important because it can be used to study the genetic makeup of organisms and how they respond to environmental changes.
Sequencing by Synthesis:
Sequencing by synthesis is a new technology that allows the generation of long reads (more than 100 bp) from short oligonucleotides. It's major advantage is that it can be used to sequence an entire genome in less time than it takes to run a single PCR reaction. This makes SBS an attractive alternative for high-throughput sequencing applications, especially next-generation sequencing (NGS).
Sequencing by Ligation:
Sequencing by Ligation is a new technology that allows the sequencing of DNA fragments of any length. It involves the ligation of a labeled oligonucleotide to the target DNA and then amplification using PCR.
Application Insights:
Oncology was the largest revenue-generating segment in 2016, owing to an increase in cancer prevalence and a rise in demand for precision medicine. The introduction of next-generation sequencing (NGS) technologies has led to an increase in oncology research studies that make use of these platforms. NGS allows researchers to identify mutations with high accuracy, which is expected to drive the market over the forecast period.
The life science segment is expected register the highest CAGR during the study period owing to technological advancements and rising adoption of HTS solutions by academic institutions and pharmaceutical companies for drug discovery & development as well as disease diagnosis. Increasing investments by governments for supporting life science applications are also likely to contribute towards growth during this timeframe. For instance, China¢â‚¬â„¢s investment of USD 142 billion from 2014 - 2018 toward biopharmaceutical development is projected to fuel industry expansion over this timeframe.
Regional Analysis:
North America dominated the global high-throughput sequencing market in 2017. This can be attributed to the presence of a large number of players, increased funding for genome research and an effective regulatory framework that supports innovation. The Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government investments in healthcare infrastructure development coupled with rising demand for advanced diagnostic techniques and personalized medicine. Moreover, growing awareness about genetic tests will drive regional growth during the forecast period.
The Asia Pacific was followed by Europe which accounted for around 27% of total revenue share in 2017 due to its well-developed healthcare sector along with supportive regulations regarding usage & approval of genomic tests In Latin America, countries such as Brazil are making significant investments on sequencing technologies owing to their rapidly improving health care systems and rising prevalence of infectious diseases such as Zika Virus (ZIKV) & Ebola Virus Disease (EVD).
Growth Factors:
- Increasing demand for personalized medicine: The increasing demand for personalized medicines is one of the key growth drivers for the HTS market. This is because HTS helps in the identification of novel biomarkers and drug targets, which are essential for the development of targeted therapies.
- Advances in sequencing technology: The advances in sequencing technology are another key growth driver for the HTS market. This is because these advances have led to the development of new and more efficient sequencing platforms, which are helping to reduce sequencing costs.
- Growing number of sequenced genomes: The growing number of sequenced genomes is another key growth driver for the HTS market. This is because it has resulted in an increase in data volumes, which has helped to improve accuracy and efficiency while conducting sequence analysis studies.
Scope Of The Report
Report Attributes
Report Details
Report Title
High-Throughput Sequencing (HTS) Market Research Report
By Type
Sequencing by Synthesis, Sequencing by Ligation
By Application
Oncology, Hereditary Disease Detection, Life Science
By Companies
Illumina, Applied Biosystems (ABI), Roche (454), Helicos, LifeTechnologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global High-Throughput Sequencing (HTS) Market Report Segments:
The global High-Throughput Sequencing (HTS) market is segmented on the basis of:
Types
Sequencing by Synthesis, Sequencing by Ligation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Hereditary Disease Detection, Life Science
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Applied Biosystems (ABI)
- Roche (454)
- Helicos
- LifeTechnologies
 Market Overview.svg)
Highlights of The High-Throughput Sequencing (HTS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sequencing by Synthesis
- Sequencing by Ligation
- By Application:
- Oncology
- Hereditary Disease Detection
- Life Science
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High-Throughput Sequencing (HTS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
High-throughput sequencing (HTS) is a technique for sequencing large numbers of DNA or RNA molecules at once. This allows researchers to rapidly sequence large amounts of data, which can be used to identify and study the genetic makeup of organisms.
Some of the major companies in the high-throughput sequencing (hts) market are Illumina, Applied Biosystems (ABI), Roche (454), Helicos, LifeTechnologies.
The high-throughput sequencing (hts) market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High-Throughput Sequencing (HTS) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 High-Throughput Sequencing (HTS) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 High-Throughput Sequencing (HTS) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the High-Throughput Sequencing (HTS) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global High-Throughput Sequencing (HTS) Market Size & Forecast, 2020-2028
4.5.1 High-Throughput Sequencing (HTS) Market Size and Y-o-Y Growth
4.5.2 High-Throughput Sequencing (HTS) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Sequencing by Synthesis
5.2.2 Sequencing by Ligation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Hereditary Disease Detection
6.2.3 Life Science
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global High-Throughput Sequencing (HTS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 High-Throughput Sequencing (HTS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Sequencing by Synthesis
9.6.2 Sequencing by Ligation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Hereditary Disease Detection
9.10.3 Life Science
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Sequencing by Synthesis
10.6.2 Sequencing by Ligation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Hereditary Disease Detection
10.10.3 Life Science
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Sequencing by Synthesis
11.6.2 Sequencing by Ligation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Hereditary Disease Detection
11.10.3 Life Science
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Sequencing by Synthesis
12.6.2 Sequencing by Ligation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Hereditary Disease Detection
12.10.3 Life Science
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Sequencing by Synthesis
13.6.2 Sequencing by Ligation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Hereditary Disease Detection
13.10.3 Life Science
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 High-Throughput Sequencing (HTS) Market: Competitive Dashboard
14.2 Global High-Throughput Sequencing (HTS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Applied Biosystems (ABI)
14.3.3 Roche (454)
14.3.4 Helicos
14.3.5 LifeTechnologies
